Biostar Pharmaceuticals announced consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the year, sales were $61,416,587, loss from operations was $1,312,695, income before income taxes was $1,534,631 and net income was $4,848,212 or $0.33 per diluted share against sales of $52,729,054, income from operations of $508,221, income before income taxes of $2,656,026 and net income of $809,046 or $0.07 per diluted share a year ago. Net cash provided by operating activities was $3,310,618 against $8,909,113 a year ago. Purchase of property, plant and equipment was $2,869,204 against $982,012 a year ago.

Net sales in the fourth quarter of 2014 was $14.4 million as compared to $11.0 million during the same period in 2013, representing a $3.4 million, or 31.0% increase. Net income for the quarter was $2.7 million.